Trial Information

Summary: Type 1 Diabetes- two different insulin treatments.

Montefiore Medical Center is currently looking for subjects between the ages of 3 and 18 years old to participate in a research study comparing two different types of insulin treatment for Type 1 Diabetes.

The study will last for about 5 months. Study drug, study supplies and procedures will be made available at no cost to subjects. Compensation will be provided for time and travel expenses.

To qualify you or your child must:

  • Be diagnosed with type 1 Diabetes.
  • Have been using an insulin pump for a minimum of 3 months.
  • Be between the ages of 3 and 18 years old.
  • Not be pregnant, nursing or plan to become pregnant during the duration of the study.

For more information,

Contact:

Hadassah Nussbaum, Study Coordinator
Biomedical Research Alliance of New York
Montefiore Medical Center
Division of Pediatric Endocrinology
111 East 210th Street
Bronx, NY 10467
Telephone: 718-920-7664
Email:

Profile Page: Biomedical Research Alliance of New York, Bronx, NY

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:


Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 5:44:20 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA